MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
-28.15%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$77.1M
AUM Growth
+$77.1M
(-43%)
Cap. Flow
-$6.34M
Cap. Flow
% of AUM
-8.22%
Top 10 Holdings %
Top 10 Hldgs %
97.81%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$4.17M |
| 2 |
SLN
Silence Therapeutics
SLN
|
$2.17M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $30.8M | 39.88% | 6,164,548 -835,452 | -12% | -$4.17M |
|
2
Invivyd
IVVD
$204M
| $10.2M | 13.19% | 9,248,250 | – | – |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $8.3M | 10.76% | 385,680 | – | – |
|
4
Fractyl Health
GUTS
$68.8M
| $7.93M | 10.27% | 1,856,117 | – | – |
|
|
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
| $4.16M | 5.39% | 110,400 | – | – |
|
|
SLN
6
Silence Therapeutics
SLN
$227M
| $3.52M | 4.56% | 185,100 -114,300 | -38% | -$2.17M |
|
7
BridgeBio Pharma
BBIO
$9.89B
| $3.07M | 3.98% | 121,200 | – | – |
|
8
Curis
CRIS
$20.9M
| $2.91M | 3.77% | 421,951 | – | – |
|
9
TG Therapeutics
TGTX
$4.65B
| $2.87M | 3.73% | 161,600 | – | – |
|
10
Arrowhead Research
ARWR
$3.05B
| $1.75M | 2.27% | 67,400 | – | – |
|
11
ProQR Therapeutics
PRQR
$237M
| $1.69M | 2.19% | 1,019,498 | – | – |
|